1.What is coronary thrombosis? Explained Coronary thrombosis occurs when a blood clot forms in one of the arteries that supply blood to the heart muscle
What is it?
Coronary thrombosis is the formation of a blood clot (thrombus) inside a coronary artery. These arteries are responsible for supplying oxygen and nutrient-rich blood to the heart muscle.
Causes and Mechanism (How it happens):
- Atherosclerosis: It usually starts with atherosclerosis, a condition where fatty deposits, cholesterol, and other substances build up in the artery walls to form plaques.
- Clot Formation: When a plaque ruptures or is damaged, platelets in the blood gather at the site and form a clot to heal it.
- Result: This clot can suddenly narrow or completely block the coronary artery, severely restricting blood flow. If the heart muscle is deprived of oxygen for too long, it leads to a Heart Attack (Myocardial Infarction).
Key Symptoms:
Chest discomfort or tightness, breathlessness, sweating, and pain that radiates to the arms, shoulders, neck, or jaw.
Diagnosis
- ECG (Electrocardiogram): To check the electrical activity of the heart.
- Blood Tests: To measure cardiac troponin levels, which indicate heart muscle damage.
- Coronary Angiography: An X-ray imaging test using a contrast dye to locate the exact blockage.
Treatment:
- Medicines: Antiplatelets (to stop platelets from clumping), anticoagulants (blood thinners), and clot-dissolving drugs.
- Surgical Procedures: Angioplasty (inflating a small balloon to open the artery and placing a mesh tube called a stent) or Coronary Artery Bypass Surgery to reroute blood flow.
Risk Factors:
High blood pressure, high LDL (bad) cholesterol, diabetes, smoking, obesity, and a sedentary lifestyle.
2. Tamil Nadu’s claim of Cauvery backlog and the Supreme Court’s response | Explained
The Core Issue (Why in News?)
The ongoing dispute between Tamil Nadu (lower riparian state) and Karnataka (upper riparian state) over the sharing of Cauvery river water has flared up again due to a severe failure of the Southwest Monsoon (June–September), leading to a 30% rainfall deficit in the Cauvery catchments.
Tamil Nadu’s Stand
- The Backlog: Tamil Nadu claims a massive shortfall (backlog) of around 11.7 to 15.02 tmc ft of water at Biligundulu (the inter-State border measuring point).
- Current Needs: TN argues that the current allocation of 3,000 cusecs (cubic feet per second) is vastly inadequate to save the Samba paddy crop in the Cauvery delta region, directly threatening farmers' livelihoods.
- TN argues that relying on the impending Northeast Monsoon (October–December) is risky, as it is highly unpredictable.
Karnataka’s Stand
- Karnataka states it is facing severe drought conditions, with a 54% deficit in inflows into its own four Cauvery basin reservoirs.
- It argues that it must prioritise its limited water for drinking water requirements and environmental flows (45 tmc ft) before releasing water to TN.
The Supreme Court’s Response
- A Division Bench of the Supreme Court practically sided with reality over mathematical quotas, asking Tamil Nadu: "How do you expect them to fulfil the backlog? They are also reeling from water scarcity."
- The Court established a practical precedent: a water backlog can only be cleared when there is excess water, not during a shared drought.
Quick facts
- Geography: The failure of the Southwest Monsoon is the primary driver of this crisis. The Northeast Monsoon (winter monsoon) is vital for TN but highly variable.
- Agriculture: The water is critically needed for the Samba cultivation season (long-duration paddy crop) in the Cauvery delta.
- Important Locations: Biligundulu is the crucial inter-State border point where water flow from Karnataka to TN is measured. Key Karnataka dams involved are Krishnaraja Sagara (KRS) and Kabini.
- Polity & Institutions: The dispute is currently managed by the Cauvery Water Management Authority (CWMA) and assisted by the Cauvery Water Regulation Committee (CWRC). These bodies implement the final award of the Cauvery Water Disputes Tribunal (modified by the SC in 2018, valid until 2033).
3.Supreme Court wants cap on trade margin for all essential medicines and medical products
The Core Issue
The Supreme Court is hearing petitions regarding the exorbitant mark-ups (sometimes up to 1,000%) charged by retailers and corporate hospitals on non-scheduled medicines and medical devices. For example, the Court noted instances like a ₹11 saline drip being sold for ₹270, and a ₹2,700 cancer drug given an MRP of ₹27,000. The Bench termed these practices "broad daylight dacoity".
The Government's Proposal
- 30% Cap on Cancer Drugs: The Union Government proposed implementing a Trade Margin Rationalisation (TMR) policy, which caps the trade margin (the profit gap between the price to retailer and the MRP) at 30% for all non-scheduled anti-cancer medicines.
- Expected Impact: This move is estimated to reduce the MRP of anti-cancer drugs by 20% to 70%, saving patients approximately ₹2,500 crore annually.
The Supreme Court's Response
- While appreciating the move for cancer drugs, the Supreme Court questioned why the cap is not being extended to all essential medicines and medical products.
- The government argued against a uniform cap across all drugs, stating that low-cost medicines need higher margins to remain commercially viable for retailers, especially to ensure availability in rural areas.
Important Institutions & Frameworks:
- NPPA (National Pharmaceutical Pricing Authority): The central regulatory body responsible for fixing, revising, and monitoring drug prices in India.
- DPCO (Drugs (Prices Control) Order), 2013: An order issued under the Essential Commodities Act. It regulates the prices of drugs.
- Scheduled Medicines: Listed under the National List of Essential Medicines (NLEM). Their prices are strictly capped by the government, allowing a standard 16% retailer margin.
- Non-Scheduled Medicines: Manufacturers are free to fix the initial launch price, but the NPPA ensures the MRP cannot be increased by more than 10% per year.
Relevance to India and Tamil Nadu:
- Out-of-Pocket Expenditure (OOPE): India has a very high rate of out-of-pocket health expenditure. Regulating trade margins directly reduces the financial burden on citizens.
- Tamil Nadu Context: Tamil Nadu boasts one of the most advanced healthcare systems in India and is a hub for private healthcare and medical tourism. However, exorbitant billing by private corporate pharmacies heavily impacts the middle and lower-middle class. Strict implementation of NPPA guidelines ensures that TN's citizens can afford life-saving treatments without falling into poverty
4. Chennai Ring Main Project worth Rs. 3,108 crore: CM Vijay to lay foundation stone today.
Background Stat: Currently, the Chennai Metropolitan Water Supply and Sewerage Board (CMWSSB) supplies 1,200 Million Litres per Day (MLD) of drinking water to about 85.7 lakh families in the city.
Chennai Ring Water Pipeline Project
Why in News? Chief Minister Joseph Vijay laid the foundation stone for the Chennai Ring Water Pipeline Project at Sholinganallur on October 14, 2026.
Project Cost: ₹ 3,108.55 Crores
- Pipeline Length: 98 kilometers (iron pipelines).
- Core Objective: To ensure a seamless, uniform, and uninterrupted drinking water supply across the Chennai metropolitan area.
How it Works (The Significance):
- Currently, Chennai relies on individual pipelines from specific sources to specific areas. If one area faces a water shortage, surplus water from another source cannot be easily diverted to it.
- The Solution: This project will interconnect 9 major drinking water sources of Chennai—including key lakes like Poondi, Puzhal, Cholavaram, Chembarambakkam, and the coastal Desalination plants—into a single "ring" network.
- This interconnected grid will allow the government to easily transfer surplus water from one source to a deficit area during critical times (like droughts or local water shortages).
5. India's best cancer treatment center in Kanchipuram: Chief Minister Vijay to inaugurate in January.
Advanced Cancer Care Centre in Kanchipuram
Why in News? The Minister for Medical Education and Health Family Welfare announced that an advanced cancer care centre, built to be one of the best in India, will be inaugurated by the Chief Minister in Karapettai, near Kanchipuram, ahead of Pongal (January).
- Location: Karapettai, Kanchipuram district.
- Project Cost: ₹324 Crore.
- Capacity & Structure: A 5-storey building with 750 beds.
- Key Facilities:
- Robotic surgery theatre.
- State-of-the-art diagnostic facilities including MRI scans, pathology, hematology, and biopsy laboratories.
- Solar power infrastructure.
Policy Background:
- This initiative stems from the state budget announcement to establish one apex state-level cancer care centre along with five regional cancer care centres to decentralize oncology treatment and provide tertiary-level cancer care across Tamil Nadu.
Administrative & Social Significance :
- Reducing Chennai's Burden: Currently, most oncology patients from northern districts converge at the Cancer Institute (Adyar) or Rajiv Gandhi Government General Hospital (RGGGH) in Chennai. Karapettai provides a dedicated tertiary hub right outside the metropolis.
- Affordability: Provides high-end, subsidized, or free cancer treatments (chemotherapy, radiation, and robotic surgery) to rural and low-income families, directly cutting out-of-pocket health expenditure.
